BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 36589977)

  • 1. Epidemiological trend in scarlet fever incidence in China during the COVID-19 pandemic: A time series analysis.
    Ma Y; Gao S; Kang Z; Shan L; Jiao M; Li Y; Liang L; Hao Y; Zhao B; Ning N; Gao L; Cui Y; Sun H; Wu Q; Liu H
    Front Public Health; 2022; 10():923318. PubMed ID: 36589977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forecasting the monthly incidence of scarlet fever in Chongqing, China using the SARIMA model.
    Wu WW; Li Q; Tian DC; Zhao H; Xia Y; Xiong Y; Su K; Tang WG; Chen X; Wang J; Qi L
    Epidemiol Infect; 2022 Apr; 150():e90. PubMed ID: 35543101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Warning and Prediction of Scarlet Fever in China Using the Baidu Search Index and Autoregressive Integrated Moving Average With Explanatory Variable (ARIMAX) Model: Time Series Analysis.
    Luo T; Zhou J; Yang J; Xie Y; Wei Y; Mai H; Lu D; Yang Y; Cui P; Ye L; Liang H; Huang J
    J Med Internet Res; 2023 Oct; 25():e49400. PubMed ID: 37902815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonality and trend prediction of scarlet fever incidence in mainland China from 2004 to 2018 using a hybrid SARIMA-NARX model.
    Wang Y; Xu C; Wang Z; Yuan J
    PeerJ; 2019; 7():e6165. PubMed ID: 30671295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal epidemiology of scarlet fever in Jiangsu Province, China, 2005-2015.
    Zhang Q; Liu W; Ma W; Shi Y; Wu Y; Li Y; Liang S; Zhu Y; Zhou M
    BMC Infect Dis; 2017 Aug; 17(1):596. PubMed ID: 28854889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Epidemiological Characteristics of Scarlet Fever in Zhejiang Province, China, 2004-2018.
    Lu Q; Wu H; Ding Z; Wu C; Lin J
    Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31533311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China.
    He Y; Ma C; Guo X; Pan J; Xu W; Liu S
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resurgence of scarlet fever in China: a 13-year population-based surveillance study.
    Liu Y; Chan TC; Yap LW; Luo Y; Xu W; Qin S; Zhao N; Yu Z; Geng X; Liu SL
    Lancet Infect Dis; 2018 Aug; 18(8):903-912. PubMed ID: 29858148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating the Long-Term Epidemiological Trends and Seasonality of Hemorrhagic Fever with Renal Syndrome in China.
    Xiao Y; Li Y; Li Y; Yu C; Bai Y; Wang L; Wang Y
    Infect Drug Resist; 2021; 14():3849-3862. PubMed ID: 34584428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characteristics and spatiotemporal clustering of scarlet fever in Liaoning Province, China, 2010-2019.
    Yu W; Guo L; Shen X; Wang Z; Cai J; Liu H; Mao L; Yao W; Sun Y
    Acta Trop; 2023 Sep; 245():106968. PubMed ID: 37307889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time Series Analysis and Forecasting of the Hand-Foot-Mouth Disease Morbidity in China Using An Advanced Exponential Smoothing State Space TBATS Model.
    Yu C; Xu C; Li Y; Yao S; Bai Y; Li J; Wang L; Wu W; Wang Y
    Infect Drug Resist; 2021; 14():2809-2821. PubMed ID: 34321897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in respiratory diseases before and after the COVID-19 pandemic in China from 2010 to 2021.
    Zuo Z; Yang C; Ye F; Wang M; Wu J; Tao C; Xun Y; Li Z; Liu S; Huang J; Xu A
    BMC Public Health; 2023 Feb; 23(1):217. PubMed ID: 36721137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological study of scarlet fever in Shenyang, China.
    Chen H; Chen Y; Sun B; Wen L; An X
    BMC Infect Dis; 2019 Dec; 19(1):1074. PubMed ID: 31864293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the epidemiological characteristics and incidence trend of scarlet fever in Shanghai, 2005-2012].
    Ren H; Wang Y; Chen ML; Yuan ZA; Li YT; Huang P; Hu JY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jul; 34(7):706-10. PubMed ID: 24257173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of meteorological changes on the incidence of scarlet fever in Hefei City, China.
    Duan Y; Huang XL; Wang YJ; Zhang JQ; Zhang Q; Dang YW; Wang J
    Int J Biometeorol; 2016 Oct; 60(10):1543-1550. PubMed ID: 26932715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporal clustering and meteorological factors affected scarlet fever incidence in mainland China from 2004 to 2017.
    Rao HX; Li DM; Zhao XY; Yu J
    Sci Total Environ; 2021 Jul; 777():146145. PubMed ID: 33684741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of meteorological factors on scarlet fever in Jiangsu province, China.
    Zhang Q; Liu W; Ma W; Zhang L; Shi Y; Wu Y; Zhu Y; Zhou M
    Public Health; 2018 Aug; 161():59-66. PubMed ID: 29909092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of meteorological parameters for forecasting scarlet fever morbidity in Tianjin, Northern China.
    Wang Y; Xu C; Ren J; Li Y; Wu W; Yao S
    Environ Sci Pollut Res Int; 2021 Feb; 28(6):7281-7294. PubMed ID: 33026621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spatial clustering analysis of scarlet fever incidence in China from 2016 to 2020].
    Zhang J; Yang R; He S; Yuan P
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):644-648. PubMed ID: 37202202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.